2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Oral Session

[O2] Oral Session 2 Head and Neck Cancer
【E】

Thu. Feb 17, 2022 8:30 AM - 10:00 AM Room 7 (Room E, 1F, Kyoto International Conference Center)

Chair:Hironaga Satake(Department of Medical Oncology, Kochi Medical School),Motoo Nomura(Department of Clinical Oncology, Kyoto University Hospital)
Discussant:Yuji Murakami(Department of Radiation Oncology, Hiroshima University Hospital)

Hideaki Bando1, Ichiro Kinoshita2, Shanu Modi3, Junji Tsurutani4, Yung-Jue Bang5, Hiroji Iwata6, Yuta Sato7, Shunsuke Nakatani7, Caleb Lee8, Masahiro Sugihara7, Yasuyuki Okuda7, Shunji Takahashi9 (1.National Cancer Center Hospital East, Chiba, Japan, 2.Hokkaido University Hospital, Hokkaido, Japan, 3.Memorial Sloan Kettering Cancer Center, New York, NY, United States, 4.Showa University, Tokyo, Japan, 5.Seoul National University Hospital, Seoul, Republic of Korea, 6.Aichi Cancer Center Hospital, Aichi, Japan, 7.Daiichi Sankyo Co., Ltd., Tokyo, Japan, 8.Daiichi Sankyo, Inc., Basking Ridge, NJ, United States, 9.The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan)

Yasuyoshi Sato1,2,3, Seto Akira4, Kobayashi Yukari3, Nagaoka Koji3, Nakano Kenji1, Sato Yukiko5, Kamiyama Ryosuke4, Shimbashi Wataru4, Sasaki Toru4, Fukushima Hirofumi4, Yonekawa Hiroyuki4, Takahashi Shunji1,2, Mitani Hiroki4, Kakimi Kazuhiro3 (1.Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 2.Division of Clinical Research, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3.Department of Immunotherapeutics, The University of Tokyo Hospital, 4.Department of Head and Neck Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 5.Department of Pathology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research)

Ayaka Sato1,2, Masahiko Tanabe1, Yumi Tsuboi2, Asako Sasahara1, Takayoshi Niwa1, Aya Shinozaki-Ushiku3, Yoshinori Murakami2, Yasuyuki Seto1 (1.Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, 2.Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, 3.Department of Pathology, Graduate School of Medicine, The University of Tokyo)

Masanobu Sato1,3, Tomohiro Enokida1, Akihisa Wada1, Susumu Okano1, Hideki Tanaka1, Takao Fujisawa1, Yuri Ueda1, Atsushi Motegi2, Takeshi Shinozaki3, Wataru Okano3, Toshifumi Tomioka3, Yohei Morishita3, Naohiro Takeshita1, Nobukazu Tanaka1, Sadamoto Zenda2, Kazuto Matsuura3, Tetsuo Akimoto2, Ryuichi Hayashi3, Makoto Tahara1 (1.Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, 2.Department of Radiation Oncology and Particle Therapy, National Cancer Center Hospital East, 3.Department of Head and Neck Surgery, National Cancer Center Hospital East)